Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/301% above fair value
$100.72−1.60 (-1.56%)
Close on Nov 18, 2026Market cap $128.84BP/E 24.7Yield 2.82%
Medtronic net income
Net income is the profit left for shareholders after every expense, interest and tax.
Medtronic's net income for the twelve months ending Jul 31, 2026 was $5.23B, up 12.3% year over year. For fiscal 2026 it was $4.80B, up 3.0% from the year before. Over ten years it grew 3.1% a year on average. The highest annual figure on record is $5.04B in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $4.80B | +3.0% |
| FY2025 | Apr 25, 2025 | $4.66B | +26.8% |
| FY2024 | Apr 26, 2024 | $3.68B | -2.2% |
| FY2023 | Apr 28, 2023 | $3.76B | -25.4% |
| FY2022 | Apr 29, 2022 | $5.04B | +39.7% |
| FY2021 | Apr 30, 2021 | $3.61B | -24.7% |
| FY2020 | Apr 24, 2020 | $4.79B | +3.4% |
| FY2019 | Apr 26, 2019 | $4.63B | +49.2% |
| FY2018 | Apr 27, 2018 | $3.10B | -22.9% |
| FY2017 | Apr 28, 2017 | $4.03B | +13.8% |
| FY2016 | Apr 29, 2016 | $3.54B | +32.3% |
| FY2015 | Apr 24, 2015 | $2.68B | -12.7% |
| FY2014 | Apr 25, 2014 | $3.07B | -11.6% |
| FY2013 | Apr 26, 2013 | $3.47B | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $1.47B | +41.3% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $1.24B | +17.8% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $1.14B | -11.7% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $1.37B | +8.2% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $1.04B | -0.2% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $1.06B | +61.5% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $1.29B | -2.1% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $1.27B | +39.7% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $1.04B | +31.7% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $654.00M | -44.5% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $1.32B | +8.2% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $909.00M | +112.9% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $791.00M | -14.9% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $1.18B | -20.6% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $1.22B | -17.4% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $427.00M | -67.4% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $929.00M | +21.8% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $1.49B | +9.2% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $1.48B | +16.5% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $1.31B | +168.1% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $763.00M | +56.7% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $1.36B | +110.5% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $1.27B | -33.7% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $489.00M | -64.1% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $487.00M | -43.6% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $646.00M | -44.9% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $1.92B | +50.9% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $1.36B | +22.3% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $864.00M | -19.6% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $1.17B | -19.7% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $1.27B | – |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $1.12B | -44.7% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $1.08B | +5.8% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $1.46B | +25.5% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | -$1.39B | -269.2% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $2.02B | +80.9% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $1.02B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $1.16B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $821.00M | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $1.12B | – |
See a number that looks wrong?